32 related articles for article (PubMed ID: 10367809)
21. The cost-effectiveness of novel direct acting antiviral agent therapies for the treatment of chronic hepatitis C.
Bickerstaff C
Expert Rev Pharmacoecon Outcomes Res; 2015; 15(5):787-800. PubMed ID: 26289734
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy in naive patients with chronic hepatitis C: more value for the money.
Koff RS
J Hepatol; 2000 Oct; 33(4):664-6. PubMed ID: 11059875
[No Abstract] [Full Text] [Related]
23. Therapy of hepatitis C: cost-effectiveness analysis.
Koff RS
Hepatology; 1997 Sep; 26(3 Suppl 1):152S-155S. PubMed ID: 9305681
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C: current and future therapies.
Mishra P; Jensen DM
Mt Sinai J Med; 2008 Aug; 75(4):405-14. PubMed ID: 18729159
[No Abstract] [Full Text] [Related]
25. Hepatitis C: An Eastern Perspective.
Dan YY; Lim SG
Gastroenterol Clin North Am; 2015 Dec; 44(4):793-805. PubMed ID: 26600220
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy forecast on interferon in the treatment of chronic viral hepatitis].
Mei YY; Gao ZL
Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):8-9. PubMed ID: 21272450
[No Abstract] [Full Text] [Related]
27. Enforcement of Legal Remedies to Secure Hepatitis C Virus Treatment With Direct-Acting Antiviral Therapies in Correctional Facilities and Medicaid Programs.
Greenwald R; Waters P; Cayer S
Public Health Rep; 2020; 135(1_suppl):44S-49S. PubMed ID: 32735189
[No Abstract] [Full Text] [Related]
28. Cost-effectiveness of interferon treatment for hepatitis C.
Henley E
JAMA; 1999 Jun; 281(22):2083; author reply 2084. PubMed ID: 10367809
[No Abstract] [Full Text] [Related]
29. [Economic evaluation of combined therapy in chronic hepatitis C].
Casado MA; Buti M; Fosbrook L; Esteban R
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():57-62. PubMed ID: 11968346
[No Abstract] [Full Text] [Related]
30. Cost-effectiveness of treatment for chronic hepatitis C.
Koff RS
J Hepatol; 1999; 31 Suppl 1():255-8. PubMed ID: 10622598
[TBL] [Abstract][Full Text] [Related]
31. Economics of chronic hepatitis B and hepatitis C.
Rajendra A; Wong JB
J Hepatol; 2007 Oct; 47(4):608-17. PubMed ID: 17697724
[TBL] [Abstract][Full Text] [Related]
32. Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.
Gellad ZF; Reed SD; Muir AJ
Antivir Ther; 2012; 17(6 Pt B):1189-99. PubMed ID: 23186646
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
